investor.immunogen.com investor.immunogen.com

investor.immunogen.com

Investors | ImmunoGen, Inc.

The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts.

http://investor.immunogen.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.IMMUNOGEN.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 16 reviews
5 star
7
4 star
4
3 star
3
2 star
0
1 star
2

Hey there! Start your review of investor.immunogen.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.2 seconds

FAVICON PREVIEW

  • investor.immunogen.com

    16x16

  • investor.immunogen.com

    32x32

  • investor.immunogen.com

    64x64

  • investor.immunogen.com

    128x128

  • investor.immunogen.com

    160x160

  • investor.immunogen.com

    192x192

CONTACTS AT INVESTOR.IMMUNOGEN.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investors | ImmunoGen, Inc. | investor.immunogen.com Reviews
<META>
DESCRIPTION
The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts.
<META>
KEYWORDS
1 about us
2 mission
3 executive officers
4 board of directors
5 in the community
6 our adc technology
7 adc design
8 with checkpoint inhibitors
9 our partners
10 kadcyla
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,mission,executive officers,board of directors,in the community,our adc technology,adc design,with checkpoint inhibitors,our partners,kadcyla,pipeline,mirvetuximab soravtansine,coltuximab ravtansine,cancer trials,partner compounds,publications
SERVER
nginx
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investors | ImmunoGen, Inc. | investor.immunogen.com Reviews

https://investor.immunogen.com

The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts.

INTERNAL PAGES

investor.immunogen.com investor.immunogen.com
1

ImmunoGen, Inc.: Annual Reports

http://investor.immunogen.com/annuals-proxies.cfm

What is an ADC? 2017 ImmunoGen, Inc. You are now leaving this website. If you would like to continue, click Continue.

2

ImmunoGen, Inc.: SEC Filings

http://investor.immunogen.com/sec.cfm

What is an ADC? All Filings (excluding Section 16). Aug 25, 2016. Aug 25, 2016. Aug 17, 2016. Aug 9, 2016. Aug 4, 2016. Jul 20, 2016. Gregory, richard j. Jul 20, 2016. Morris, charles q. Jul 20, 2016. Jul 20, 2016. Johnston, david brannon. Jul 20, 2016. 10 results per page. 25 results per page. 50 results per page. 2016 ImmunoGen, Inc. You are now leaving this website. If you would like to continue, click Continue.

3

ImmunoGen, Inc.: Financials & Filings

http://investor.immunogen.com/financials.cfm

What is an ADC? Sep 30, 2015. Sep 30, 2014. Aug 25, 2016. Aug 27, 2015. May 4, 2016. Feb 4, 2016. 2016 ImmunoGen, Inc. You are now leaving this website. If you would like to continue, click Continue.

4

ImmunoGen, Inc.: Corporate Governance

http://investor.immunogen.com/corporate-governance.cfm

What is an ADC? Appendix A - Policies and Procedures for the Submission of Shareholder Recommendations. Appendix A - Board Membership Criteria. Code of Corporate Conduct. Senior Officer and Financial Personnel Code of Ethics. 2016 ImmunoGen, Inc. You are now leaving this website. If you would like to continue, click Continue.

5

ImmunoGen, Inc.: Quarterly Reports

http://investor.immunogen.com/results.cfm

What is an ADC? ImmunoGen Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Quarterly Business Update. ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update. ImmunoGen Reports Second Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update. ImmunoGen Reports First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update. ImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2015 Financial Results. ImmunoG...

UPGRADE TO PREMIUM TO VIEW 12 MORE

TOTAL PAGES IN THIS WEBSITE

17

SOCIAL ENGAGEMENT



OTHER SITES

investor.igo.com investor.igo.com

iGo | Investor Relations

investor.ihs.com investor.ihs.com

IHS - Investor Relations - Investor Relations

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice. Https:/ my.ihsenergy.com/. Https:/ login.ihserc.com/login/erc? UK Solutions (including CIS/OHSIS). Https:/ www.ihsti.com/ihsti/index.aspx. Http:/ connect.ihs.com/. Economics and Country Risk. Engineering Knowledge and Tools. Environmental, Health and Safety. Market Insight, Forecasts and Company Analysis. Jun 2...

investor.ihsmarkit.com investor.ihsmarkit.com

Investor Relations | Investors | IHS

Stock Quote and Chart. Merger Information and Documents. Q4 2016 IHS Markit Earnings Conference Call. January 17, 2016. IHS Markit Reaffirms 2016 Guidance, Provides 2017 Guidance. November 14, 2016. IHS Markit 2016 Guidance Call Supplemental Materials. July 13, 2016. IHS Markit is a new global information leader. July 13, 2016. IHS and Markit Complete Merger to Form Global Information Powerhouse. July 12, 2016. January 11, 2017 4:00 pm ET. IHS Markit Share Related. 15,513,263,000. Click here for webcast.

investor.illumina.com investor.illumina.com

Illumina .::. Investor Relations Overview

Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe. Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market. Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015. Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics. Illumina Introduces Illumina SeqLab. Q2 2015 Illumina, Inc. Earnings Conference Call. 160; 0.84. Data as of 08/07/15 4:00 pm ET.

investor.immucor.com investor.immucor.com

Investor Relations | Immucor, Inc. – IR Site

Skip to main navigation. China (ä æ ). Japan (æ æœ èªž). Vision, Mission and Values. Reagent Red Blood Cells. Founded in 1982 and based in Norcross, GA, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient/donor compatibility. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. Jan 16, 2018. Avi Pelossof Appointed President and CEO of Immucor. Jul 26, 2017.

investor.immunogen.com investor.immunogen.com

Investors | ImmunoGen, Inc.

Skip to main navigation. What is an ADC? What is an ADC? And in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. More information about the Company can be found at www.immunogen.com. Mar 24, 2018. ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Society of Gynecologic Oncology Annual Meeting. Mar 14, 2018. May 9, 2018 at 9:20 AM EDT. May 9, 2018. There are no items to display.

investor.impinj.com investor.impinj.com

IMPINJ | Investor Relations

01/11/17  4:00 pm ET. Data Provided by Nasdaq. Minimum 15 minutes delay. Impinj to Present at Needham Growth Conference. Impinj, Inc. Announces Closing of Follow-On Public Offering and Full Exercise of the Underwritersâ Option to Purchase Additional Shares. Impinj, Inc. Announces Pricing of Follow-On Public Offering. There are currently no events scheduled. Chat with us on social media.

investor.imprivata.com investor.imprivata.com

Healthcare IT & Communications Solutions | Imprivata Investor Relations |

Skip to main content. Events and Live Webinars. Authentication and Access Management. Imprivata OneSign, ranked #1 by KLAS for single sign-on, delivers fast, secure No Click Access to patient information. Imprivata Cortext is the secure communications platform that enables healthcare organizations to replace pagers and improve care coordination, inside and outside the hospital. E-prescribing of Controlled Substances. Imprivata provides insights on industry leading issues. State & Local Government/CJIS.

investor.inasentence.org investor.inasentence.org

investor in a sentence | simple examples

In A Sentence .org. The best little site that helps you understand word usage with examples. Investor in a sentence. In its Future,. Use bellys in a sentence. Use buccaneers in a sentence. Use calamanco in a sentence. Use flowerpot in a sentence. Use glandular in a sentence. Use gyrostatics in a sentence. Use justifier in a sentence. Use overprinted in a sentence. Use prohibitively in a sentence. Use rotating in a sentence. Popular Words This Week. In its Future, Investors. They are their investors.

investor.incontact.com investor.incontact.com

inContact | Investor Relations | Investor Relations

Q2 2015 inContact, Inc. Earnings Conference Call. 160;at 4:30 pm ET. 160; 2.68. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. InContact Reports Second Quarter 2015 Financial Results. InContact CEO Paul Jarman and CFO Greg Ayers to Present at the Oppenheimer 18th Annual Technology, Internet and Communications Conference. InContact Sets Second Quarter 2015 Conference Call. International Business Process Outsourcer Expands Existing inContact Solution with Workforce Management in the Cloud.

investor.incyte.com investor.incyte.com

Investor Relations | Incyte

The Drive to Discover. The Experience to Deliver. Jakafi and Disease Education. Q2 2015 Incyte Corporation Earnings Conference Call. 160;at 10:00 am ET. Q2 2015 Incyte Corporation Earnings Conference Call. Tuesday, August 4, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Incyte’s mission is to become one of the leading global oncology companies. August 04, 2015. July 14, 2015. Incyte to Report Second Quarter Financial Results on August 4. WILMINGTON, Del....